The cost of tissue plasminogen activator (tPA), or alteplase, a clot-busting drug used to treat stroke patients, has doubled in the past decade, while reimbursement to hospitals for the use of tPA has ...

WASHINGTON, Aug. 4-Medicare is about to announce that beginning in October it will start paying hospitals for use of the thrombolytic drug tissue plasminogen activator (tPA) for treatment of ischemic ...

CLEAR III tested the benefits of the clot-busting drug alteplase, also known as tPA, in improving outcomes for intraventricular hemorrhage. In this particularly severe form of stroke, blood pools and ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside ...

Ten years ago, a crucial study proved that a drug could limit the damage from one of nature's biggest train wrecks: a blood clot stuck inside the head. The drug, TPA, was so powerful at dissolving ...

Stroke victims treated with TPA were twice as likely to have a good outcome as those who were not. The Food and Drug Administration approved it for stroke the next year, and a move grew to treat ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

HUDSON — Columbia Memorial Hospital has a new way to fight strokes. The hospital is using a new clot-busting drug known as Tissue Plasminogen Activator, or TPA. The New York state Department of Health ...

BOSTON, Sept 24 (Reuters) - Doctors are given just three hours to administer the clot-busting drug alteplase to help stroke patients, but a study released on Wednesday shows the drug still does some ...

For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later ...

BOSTON (Reuters) - Doctors are given just three hours to administer the clot-busting drug alteplase to help stroke patients, but a study released on Wednesday shows the drug still does some good as ...